Human ACE2 transgenic mouse model
Updated time: 2021-05-24 17:16:31
Human ACE2 transgenic mouse model
Docket Number
13A-1090928
Announcement Date
2020-10-08
IP Status
USP Pending
Abstract
This invention is to establish mouse model for COVID-19 study. Human ACE2 gene that encodes the receptor of COVID-19 was injected into fertilized oocytes to select transgenic mice expressing human ACE2 protein. The human ACE2 gene was designed to be controlled by an ubiquitous promoter. Consequently, human ACE2 proteins were highly express in variety of mouse tissues. This mouse model is suitable for vaccine development and drug screening of COVID-19.
Technological Advantages
- High expression of human ACE2 protein in transgenic mice.
- Stable expression of human ACE2 protein in transgenic mice.
- Ubiquitous expression of human ACE2 proteins in a variety of mouse tissues and organs allows to investigate and monitor simultaneously the responses of mice to COVID-19 infection in different organs, which is similar to patients’ condition.
- Suitable to age study
- High susceptibility to COVID-19 virus.
- Easy to breed and maintain.
Applications of Technology
- COVID-19 vaccine development
- COVID-19 infection study
- Drug screening for COVID-19
Inventor
Ching-Yen Tsai、Yi-Ping Hsueh
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Human ACE2 transgenic mouse model